Work

Faculty Opinions recommendation of Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.

Year: 2021

Type: peer-review

Abstract: Read the full review for this Faculty Opinions recommended article: Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected.

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.739017049.793585091

Authors: Angus Nairn, Shannon Leslie

Institutions: Connecticut Mental Health Center, Yale University

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4206988146

Cites:

Cited by: 1

Related to: 10